A British pharmaceutical company on Monday said that positive results from a clinical trial of a new coronavirus respiratory treatment could signal a “major breakthrough” in the global fight to stop the spread of COVID-19.Synairgen, a respiratory drug discovery and development company, said in a news release that an initial trial showed that the odds of developing severe disease reduced by 79 percent for hospitalized patients receiving its…
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over